Teladoc Health (NYSE: TDOC) shares have tumbled about 70% this year. Teladoc is making progress on its goal of "whole person" care -- from mental health to physical health. The telemedicine market is set to grow in the double digits this decade.
It's been a difficult year for stocks (and investors) in general. But certain stocks have had a particularly trying time. These companies faced specific challenges -- and that's sent their shares tumbling further than the general market.
In 2022, these once seemingly unstoppable investments have plunged into the red, undoubtedly impacting many portfolios.